Neurotrophic Effects of a Cyanine Dye via the PI3K-Akt Pathway: Attenuation of Motor Discoordination and Neurodegeneration in an Ataxic Animal Model by Ohta, Hitomi et al.
Neurotrophic Effects of a Cyanine Dye via the PI3K-Akt
Pathway: Attenuation of Motor Discoordination and
Neurodegeneration in an Ataxic Animal Model
Hitomi Ohta*, Shigeyuki Arai, Kenji Akita, Tsunetaka Ohta, Shigeharu Fukuda
Research Center, Biomedical Institute, Hayashibara Biochemical Laboratories, Inc., Okayama, Japan
Abstract
Background: Neurotrophic factors may be future therapeutic agents for neurodegenerative disease. In the screening of
biologically active molecules for neurotrophic potency, we found that a photosensitizing cyanine dye, NK-4, had remarkable
neurotrophic activities and was a potent radical scavenger.
Methodology/Principal Findings: In this study, we evaluated the effect of NK-4 on the protection of neurons against
oxidative damage and investigated the associated intracellular signaling pathways. Subsequently, we evaluated the effect of
NK-4 in an animal model of neurodegeneration. In vitro, NK-4 showed dose-dependent protection of PC12 cells from toxicity
induced by oxidative stress caused by hydrogen peroxide (H2O2) or 6-hydroxydopamine (6-OHDA). Comparison of
extracellular signal-regulated kinase signaling pathways between treatment with NK-4 and nerve growth factor (NGF) using
K252a, an inhibitor of the NGF receptor TrkA, revealed that NK-4 activity occurs independently of NGF receptors. LY294002,
a phosphatidylinositol 3-kinase (PI3K) inhibitor, blocked the protective effect of NK-4, and NK-4 caused activation of Akt/
protein kinase B, a downstream effector of PI3K. These results suggest that the neuroprotective effects of NK-4 are mediated
by the PI3K-Akt signaling pathway. NK-4 treatment also attenuated stress-induced activation of SAPK/JNK, which suggests
that NK-4 activates a survival signaling pathway and inhibits stress-activated apoptotic pathways independently of the TrkA
receptor in neuronal cells. In vivo, administration of NK-4 improved motor coordination in genetic ataxic hamsters, as
assessed by rota-rod testing. Histological analysis showed that cerebellar atrophy was significantly attenuated by NK-4
treatment. Notably, the Purkinje cell count in the treated group was threefold higher than that in the vehicle group.
Conclusions/Significance: These results suggest that NK-4 is a potential agent for therapy for neurodegenerative disorders
based on the activation of survival signaling pathways.
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Introduction
Neurodegenerative diseases including Alzheimer’s disease (AD),
Parkinson’s disease (PD), and motor neuron diseases are an
enormous growing public health burden globally. Thus, there is a
clear need to develop therapies that will halt or reverse their
progression. Neurotrophic factors may serve as therapeutic agents
because they play key roles in coordination of brain development
and maintenance of brain function in adulthood. Indeed, the use
of neurotrophic factors such as nerve growth factor (NGF) and
brain derived neurotrophic factor (BDNF) for treatment of
neurodegenerative diseases is widely advocated, based mainly on
in vitro observations and preliminary success in animal models of
AD, PD, Huntington disease, Rett syndrome, traumatic brain
injury, and aging [1–6]. However, several properties limit the
therapeutic application of neurotrophic factors. Their large size
causes poor blood brain barrier penetration [7], and high
antigenicity may lead to failure of long term efficacy. NGF and
BDNF also interact at low affinity with the P75 receptor, and this
might contribute to promotion of pain and other undesirable
effects [8]. Therefore, small molecules are required as therapeutic
agents that have high and long-lasting neurotrophic potency and
do not cause serious adverse effects.
Therapies that promote cellular events including proliferation,
differentiation, and migration, neurite-outgrowth, synaptogenesis,
and myelination of neurons are needed for many neurodegerative
diseases. Proliferation and growth of axonal and dendritic
processes (neurites) are critical determinants of neuronal function,
and disruption of these processes can lead to neuronal dysfunction.
The PC12 cell line has been widely used in neurobiology to
evaluate chemical effects on neurite-outgrowth [9–11]. Following
exposure to neurotrophic factors such as NGF, PC12 cells
proliferate and differentiate into a sympathetic neuron-like
morphology, and develop extensive neuritic processes in a
concentration-dependent manner [12]. Thus, we screened biolog-
ically active molecules for neurotrophic potency using PC12 cells,
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remarkable neurotrophic activities.
Cyanine dyes have been studied for over 150 years and continue
to be of interest in biology and medicine [13]. One of these dyes,
NK-4, has a variety of biological activities, including antimicrobial
[14], macrophage-activating [15] and anticancer [16] properties,
and is used practically as an immunomodulator in treatment with
antiviral and anticancer agents [17]. However, the effect of
cyanine dyes on neurodegenerative disease is not well established.
Recently, we identified NK-4 as the most potent radical scavenger
among a series of cyanine dyes, and found that NK-4 was effective
for treatment of cerebral ischemia [18]. Thus, we focused on NK-
4 as an agent for treatment of neurodegeneration.
Tropomyosin-related kinases (Trks) are essential for neurotro-
phin family-mediated cellular events, including neuronal survival,
differentiation, and synaptic function [19] via activation of
downstream signaling mediators of phosphatidylinositol 3-kinase
(PI3K) and the survival signaling kinase Akt [20]. In a therapeutic
context, Akt has been shown to mediate striking neurotrophic and
anti-apoptotic effects in vivo [21]. In contrast, in relation to
neuronal degeneration, oxidative stress may cause activation of
stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/
JNK). Inhibition of the SAPK/JNK pathway by activation of
PI3K-Akt has been proposed as a potential therapeutic target in
neurodegenerative diseases [22]. These observations suggest that
PI3K-Akt is of particular therapeutic interest, and it is likely that
therapeutic targets related to kinase signaling pathways will
emerge.
Hamsters with inheritable ataxia, an autosomal recessive trait,
were used to evaluate the preclinical efficacy of NK-4. This ataxic
animal originally arose spontaneously in one of our breeding
colonies, and shows typical clinical signs of ataxic gait, including a
slight trembling of the head, unsteady walking, and stumbling after
7 weeks of age [23,24]. These ataxic symptoms were well correlated
with the cerebellum atrophy and Purkinje cells degeneration. The
Purkinje cell degeneration of the mutant was characterized by
suppression of Nna1, a gene discovered in an axonal regenerative
context [23,25]. Similarly, abnormal development of Purkinje cell
dendrites in mice with Purkinje cell degeneration has been linked to
a deletion mutant in exon 7 of Nna1 [26]. We refer to the ataxic
mutant line as hmPCD (hamster PCD).
In this study, we demonstrate that NK-4 has potent neuro-
trophic activity and protects neuronal cells against toxicity,
including oxidative stress, by activating the PI3K-Akt signaling
pathway in vitro. We further show that administration of NK-4 to
the ataxic hamster significantly improved motor discoordination,
with reversal of damage to Purkinje cells and the cerebellum.
Methods
Ethics Statement
All animal protocols were approved by the Institutional Animal
Care and Use Committee of Hayashibara Biochemical Labora-
tories (permit number F-902), and were conducted in accordance
with the guidelines of the Care and Use of Laboratory Animals at
Hayashibara Biochemical Laboratories.
Chemicals
NK-4 (4,49-[3-{2-(1-ethyl-4(1H)-quinolylidene)ethylidene}pro-
penylene]bis(1- ethylquinolinium iodide)) was synthesized at
Hayashibara Biochemical Laboratories, Inc. (Okayama, Japan).
A stock solution of 6.3 mM NK-4 was prepared in DMSO (Sigma,
St. Louis, MO) and stored at room temperature with protection
from light. Just before use, the stock solution was diluted with
DMSO to give a 32 mM solution. This solution was used for
experiments with further dilution. NGF, K252a, and LY294002
were purchased from Wako Pure Chemical Industries (Osaka,
Japan). Phospho-Akt (Ser 473) antibody, Phospho-SAPK/JNK
(Thr183/Thr185) antibody, Akt antibody, and SAPK/JNK
antibody were obtained from Cell Signaling Technology, Inc.
(Beverly, MA), anti-calbindin D28K antibody was from Chemicon
International, Inc. (Temecula, CA) and Alexa488-conjugated anti-
rabbit IgG antibody was from Molecular Probes (Eugene, OR).
Cell Culture
The rat pheochromocytoma cell line PC12 (Human Science
Research Resources Bank, Osaka, Japan) was cultured in
Dulbecco’s Modified Eagle Medium (D-MEM; Nissui, Tokyo,
Japan) supplemented with heat-inactivated 10% fetal bovine
serum, 5% horse serum. For cell growth and neurite-outgrowth
assays, PC12 cells were harvested using 0.1% (w/v) trypsin
containing 0.03% (w/v) EDTA, and seeded at a density of 5,000
cells/100 ml in 96-well plates pre-coated with collagen type IV.
After a 24-hr pre-culture, PC12 cells were exposed to NK-4. For
neurite-outgrowth quantification, cells were treated with NK-4 at
a low concentration of NGF (5 ng/ml). Cells were incubated for
72 hr prior to evaluation of cell growth and neurite-outgrowth.
Cell survival was determined using alamarBlue dye (Trek
Diagnostic Systems, Cleveland, OH) [27]. To measure neurite-
outgrowth, cells were fixed with 4% glutaraldehyde in phosphate
buffer and visualized by phase-contrast microscopy. Representa-
tive cells were photographed for each well. The percentage of cells
with neurites that were at least twice the diameter of the cell body
was calculated. Neurites were identified and counted from ,100
cells per photograph. In some experiments a PI3K or Trk
inhibitor, LY294002 or K252a, was added at the indicated
concentration to serum-free medium and incubated for 15 min,
after which 50 ng/ml NGF or 250 nM NK-4 with 5 ng/ml NGF
was added.
Evaluation of the protective effects of NK-4 against
neurotoxic environments
Hydrogen peroxide (H2O2) and 6-hydroxydopamine (6-OHDA)
were used to produce neurotoxic environments in which to
investigate the cytoprotective effects of NK-4. PC12 cells were
seeded at a density of 2610
4 cells/100 ml in 96-well plates pre-
coated with collagen type IV and cultured for 24 hr prior to
stimulation. To investigate the effect of NK-4 on H2O2-o r6 -
OHDA-induced cytotoxicity, PC12 cells were exposed to 200 mM
H2O2 for 2 hr or 100 mM 6-OHDA for 24 hr in the presence or
absence of NK-4. After treatment, cell survival was assessed using
alamarBlue dye. All results were confirmed by visual inspection
using phase-contrast microscopy.
Western Blotting
After PC12 cells were treated for the indicated periods with
NK-4, the culture medium was aspirated and cells were washed
with ice-cold PBS. Subsequently, cells were homogenized with lysis
buffer [62.5 mM Tris, pH 6.8, 150 mM NaCl, 0.02% (w/v)
sodium azide, 2% (w/v) SDS, 10% glycerol, 50 mM DTT, 0.01%
(w/v) bromophenol blue] and sonicated for 10 sec. Equal amounts
of protein (20 mg) were separated on a SDS polyacrylamide gel
and transferred to a nitrocellulose membrane (Osmonics, Inc.,
Gloucester, MA). Blots were blocked for 1 h at room temperature
with 5% (w/v) nonfat dried milk in Tris-buffered saline (10 mM
Tris, pH 7.6, and 150 mM NaCl) containing 0.1% Tween 20.
The membrane was incubated overnight at 4uC with specific
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and their phosphorylated forms were used in the study. The blot
was then incubated with the G-horseradish peroxidase conjugated
anti-rabbit immunoglobulin (Dako, Glostrup, Denmark). Immu-
noreactive proteins were detected with the enhanced chemilumi-
nescence Western blotting detection system. The relative density of
the protein bands was quantified by densitometry using Image
Master 2D (Amersham Pharmacia Biotec, Piscataway, NJ).
Animals
Male and female inbred homozygous ataxic mutant Syrian
hamsters (Mesocricetus auratus) and age- and sex-matched wild-type
hamsters were used in the study [23,24]. The animals were housed
individually with nesting materials supplied, and food and water
were provided ad libitum. NK-4 solution was injected intraperito-
neally at a dose of 20 or 100 mg/kg once a day for 7 weeks,
beginning at 3 weeks of age. Controls received 200 ml of saline.
Behavioral analysis
Motor coordination of ataxic animals was determined in a rota-
rod task performed every week after injection of NK-4. In this test,
animals were placed in a rota-rod apparatus (6-cm diameter,
Hayashibara Biochemical Laboratories, Inc.) with a constant
rotation rate of 6 rpm. The apparatus consisted of a horizontal
motor-driven rotating rod in which the animals were placed
perpendicular to the long axis of the rod, with the head directed
against the direction of rotation so that the hamster has to progress
forward to avoid falling. The trial was stopped when the animal
fell down or after a maximum of 180 s. The time spent in the
rotating rod was recorded for each animal and trial. All animals
received a pretraining session to familiarize them with the rotating
apparatus one week before the first test session. Subsequently, six
consecutive trials were performed for every animal in each session
every week [28,29]. The results of the sixth test were used in the
statistical comparison. At the end of the study, each hamster was
placed in a plastic cage (20630615 cm) and the spontaneous
falling frequency was counted for 60 s [30].
Volumetric measurements of hamster brain
Animals were deeply anesthetized with pentobarbital (50 mg/
kg), brains were dissected and fixed with 10% buffered-formalin
and pictured from the constant distance from the top. The sizes of
the cerebellum were measured and the volumes were calculated as
V=ab
2/2, where ‘‘a’’ and ‘‘b’’ are the lengths of the major and
minor axes of the cerebellum, respectively [31].
Histology
Brains were embedded in paraffin, and then mid-sagittal
sections of 5 mm thickness were stained with hematoxylin and
eosin (H&E). To count the calbindin-positive cells, dewaxed and
rehydrated paraffin sections were permeablized and blocked with
PBS containing 0.2% Triton X-100 and 5% BSA. The sections
were then incubated with anti-calbindin antibody (1:500) 2
overnight at 4uC diluted in PBS containing 0.1% Triton X-100
and 2% BSA. After several washes in PBS, sections were incubated
with Alexa488-conjugated secondary antibody (1:50) [32]. Calbin-
din-positive cells in the Purkinje layer were counted as Purkinje
cells. The density of granule cells was calculated in the tenth lobule
of the cerebellum.
Statistical Analysis
All values are expressed as means 6 SD or SEM. A paired t test
was used for comparison between 2 groups. One-way ANOVA
with a subsequent Tukey-Kramer test was used to determine the
significance of differences in multiple comparisons. Differences
with a probability value of P,0.05 were considered to be
significant.
Results
NK-4 promotes the growth and neurite-outgrowth of
neuronal PC12 cells
NK-4 induced PC12 cell growth (Fig. 1A) and promoted NGF-
primed neurite extension (Fig. 1B), as shown by the appearance of
neurite-outgrowth within 3 days (Fig. 1C). NK-4 alone promoted
cell growth, but did not affect the morphological differentiation of
PC12 cells. The effects of NK-4 were dose-dependent, based on
fluorometric and quantitative analysis of cellular growth and
neurite extension. The concentration at which NK-4 exerted its
maximum effect differed when assessed by growth or neurite-
outgrowth: a maximal effect was obtained at 250 nM as assessed
by cell growth, whereas a higher dose of up to 2.5 mM was needed
for neurite-outgrowth.
Effects of NK-4 in PC12 cells treated with neurotoxins
The effect of NK-4 against oxidative toxicity induced by H2O2
was examined because neurons are vulnerable to the toxic effects
of oxidative stress. In this model, the viability of cells exposed to
200 mMH 2O2 for 2 hr was about 50% compared to controls
without H2O2 exposure. NK-4 protected cells from H2O2 toxicity
in a dose-dependent manner (Fig. 2A). Since oxidative stress
induced by H2O2 occurred rapidly and severely, relatively high
concentrations of NK-4 were required to obtain a significant
protective effect. The cytoprotective effect of NK-4 was also found
using 6-OHDA, a selective catecholaminergic neurotoxin that has
been used to produce PD models in vitro and in vivo [33,34]. When
PC12 cells were cultured with 100 mM 6-OHDA for 24 hr, cell
viability was significantly decreased to 60% compared with
controls with no 6-OHDA (Fig. 2B). NK-4 dose-dependently
attenuated cell damage induced by 6-OHDA and the results were
significant at doses over 16 nM. We also found a protective effect
of NK-4 against cell damage induced by serum deprivation (data
not shown).
Given the cytoprotective effect of NK-4 against oxidative
damage, we examined if NK-4 could directly scavenge H2O2,
since it has been reported that H2O2 generated from 6-OHDA is
involved in cytotoxicity [33]. NK-4 was able to detoxify reactive
oxygen species (ROS) such as hydroxyl, superoxide and peroxy
radicals [18], but showed no effect on H2O2 scavenging at
concentrations up to 63 mM (data not shown).
NK-4 does not act via Trks
We next investigated if NK-4 acts via Trks to induce growth
and neurite-outgrowth in PC12 cells. Trks includes the NGF
receptor, Trk A, which mediates NGF-induced neuronal survival
and differentiation in PC12 cells [35]. Pretreatment with K252a, a
Trk inhibitor, dose-dependently inhibited NGF-induced cell
growth, but did not inhibit that induced by NK-4 (Fig. 3A). This
suggests that NK-4 activity occurs independently of TrkA
activation in PC12 cells. Similarly, NGF-induced neurite-out-
growth was inhibited in a concentration-dependent manner by
K252a, while the effect of NK-4 on neurite-outgrowth was not
inhibited efficiently (Fig. 3B). A high K252a concentration did
significantly decrease the effect of NK-4, which might be because
neurite-outgrowth induced by NK-4 is dependent on the presence
of a low level of NGF.
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mediated cytoprotection
To analyze the effect of NK-4 on survival and differentiation of
PC12 cells further, we next examined whether NK-4 activates
PI3K and its downstream signaling effector Akt. This cascade has
been implicated in the survival signaling caused by NGF in serum-
deprived PC12 cells, and in neuritogenesis in PC12 cells [36,37].
We examined if LY294002, a specific PI3K inhibitor, blocked the
activity of NK-4, and also determined the kinetics of Akt activation
following NK-4 treatment of PC12 cells. LY294002 caused cell
growth arrest of PC12 cells dose-dependently in the presence of
NGF and NK-4 (Fig. 4A). An inhibitory effect of LY294002 was
also found in the neurite-outgrowth assay (Fig. 4B). The
neurotrophic effects of NK-4 and NGF on PC12 cells were
similarly inhibited by the PI3K inhibitor.
Activation of Akt can be detected by Western blotting with
antibodies that specifically recognize Akt phosphorylated at Ser
473, because this phosphorylation correlates with Akt activity [38].
As shown in Fig. 5, NK-4 induced phosphorylation of Akt in a
time-dependent manner. Akt phosphorylation was detected by
5 min NK-4 treatment and maximally increased between 60 and
120 min. The dose of NK-4 required for induction of Akt
phosphorylation was consistent with that required for promotion
of PC12 cell growth. These results suggest that activation of PI3K
and its downstream signaling effector Akt are important in NK-4-
induced neurotrophic effects in PC12 cells.
Effect of NK-4 on stress-activated SAPK/JNK
We subsequently investigated whether SAPK/JNK, a major
cellular stress responsive protein induced by oxidative stress, plays
an important role in NK-4-mediated effects in PC12 cells. PC12
cells treated with cytotoxic levels of H2O2 induced SAPK/JNK
activation in PC12 cells (Fig. 6). This activation was attenuated by
NK-4 in a concentration-dependent manner, and the dose of NK-
4 was well correlated with the concentration found in the H2O2-
induced cytotoxicity model in PC12 cells. This observation
suggests that NK-4 might attenuate H2O2-induced cell death
through inhibition of SAPK/JNK activation.
Cerebellar ataxia in mutant hamsters
Given the effects of NK-4 on neurotoxicity in vitro, we evaluated
NK-4 for treatment of neurodegeneration in vivo using an ataxic
animal model in Syrian hamster characterized by Purkinje cell
degeneration (hmPCD). Homozygous mutants were viable at birth
and indistinguishable in appearance from normal controls (Fig. 7A),
but grew up to be smaller than age-matched wild type hamsters.
The mutants had a normal life span [23], but showed motor and
behavioral deficits, including abnormal tremor and unusual falling.
Figure 1. Neurotrophic effects of NK-4 in PC12 cells. (A) Effect of NK-4 on PC12 cell growth. PC12 cells were raised in D-MEM containing 10%
FBS for 72 hr in the presence or absence of NK-4. The number of cells was assessed by alamarBlue assay. (B) Effect of NK-4 on NGF-primed neurite-
outgrowth in PC12 cells. PC12 cells were treated with NGF (5 ng/ml) plus NK-4 (indicated concentrations) for 72 hr. The percentage of PC12 cells with
neurites longer than twice the diameter of the cell body was calculated. Results are shown as a mean 6 SD (n=3). **P,0.01 vs. the respective
control. (C) Phase contrast micrographs of PC12 cells. PC12 cells treated with NK-4 (1000 nM) plus NGF (5 ng/ml) (c) had longer neurites than those
treated with NK-4 (1000 nM) (a) or NGF (5 ng/ml) (b) for 72 hr. Bar: 50 mm.
doi:10.1371/journal.pone.0017137.g001
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17137Figure 2. Cytoprotective effects of NK-4 against neurotoxins in PC12 cells. (A) Effect of NK-4 on H2O2-induced cytotoxicity. PC12 cells were
treated with 200 mMH 2O2 for 2 hr in the absence or presence of the indicated concentrations of NK-4. Control cells were incubated under the same
conditions, but without H2O2.( B) Effect of NK-4 against 6-OHDA-induced toxicity. PC12 cells were treated with 100 mM 6-OHDA for 24 hr in the
absence or presence of the indicated concentrations of NK-4. Control cells were incubated under the same conditions, but without 6-OHDA. All
results were obtained by alamarBlue assay and are expressed as the percentage fluorescence of control cells. Values are means 6 SD obtained in
triplicate. *P,0.05, **P,0.01 for comparison of wells with and without NK-4.
doi:10.1371/journal.pone.0017137.g002
Figure 3. Effects of K252a, a Trk inhibitor, on PC12 cell growth (A) and neurite-outgrowth (B) induced by NK-4 (bold line) and/or
NGF (broken line). PC12 cells were preincubated in serum-free D-MEM with the indicated concentrations of K252a for 15 min. NK-4 (250 nM) or
NGF (50 ng/ml) was added and the cells were further incubated for 72 hr. In the neurite-outgrowth assay, 250 nM NK-4 with 5 ng/ml NGF, or 50 ng/
ml of NGF alone was used. The number of cells was assessed by alamarBlue assay. The percentage of cells with neurites was quantified by phase
contrast microscopy. Values are means 6 SD in triplicate. **P,0.01 vs. control.
doi:10.1371/journal.pone.0017137.g003
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PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17137Figure 4. Promotion of PC12 cell growth and neurite-outgrowth through activation of PI3K by NK-4. Effects of LY294002, a PI3K
inhibitor on cell growth (A) and neurite-outgrowth (B) induced by NK-4 (bold line) and/or NGF (broken line). PC12 cells were preincubated in serum-
free D-MEM containing the indicated concentrations of LY294002 for 15 min. NK-4 (250 nM) or NGF (50 ng/ml) was added and the cells were further
incubated for 72 hr. The number of cells was assessed by alamarBlue assay. In the neurite-outgrowth assay, 250 nM NK-4 with 5 ng/ml NGF, or 50 ng/
ml of NGF alone was used. The percentage of cells with neurites was quantified by phase contrast microscopy. Values are means 6 SD in triplicate.
**P,0.01 vs. control.
doi:10.1371/journal.pone.0017137.g004
Figure 5. Induction of Akt phosphorylation by NK-4 in PC12
cells. PC12 cells were treated with 250 nM NK-4 for the indicated times.
Whole cell lysates were analyzed by Western blotting using anti-
phospho-Akt antibody (upper panel) or anti-Akt antibody (lower panel).
The graph shows the ratio of phosphorylated Akt to total Akt at each
time point.
doi:10.1371/journal.pone.0017137.g005
Figure 6. NK-4 attenuated H2O2-induced SAPK/JNK phosphor-
ylation in PC12 cells. PC12 cells were treated with 400 mMH 2O2 in
the presence of the indicated concentrations of NK-4 for 2 hr. Whole
cell lysates were analyzed by Western blotting using anti-phospho-
SAPK/JNK antibody (upper panel), or anti-SAPK/JNK antibody (bottom
panel). The graph shows the ratio of phosphorylated SAPK/JNK to total
SAPK/JNK at each time point.
doi:10.1371/journal.pone.0017137.g006
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only briefly (Fig. 7B). Histological analysis using H&E staining
showed marked atrophy of the cerebellar cortical region of the
mutants at 48 weeks of age (Fig. 7C). Concomitantly, in the
cerebellar cortex, a large reduction in the number of Purkinje cells
was observed in the mutant brain (Fig. 7D).
Effect of NK-4 on cerebellar ataxia in hmPCD
Animals were treated with 20 or 100 mg/kg NK-4 once a day
for 7 weeks, beginning at 3 weeks of age. We designed this dose
schedule based on preliminary experiments for dosing of NK-4. In
general, the animals remained in good health throughout the
study. Motor discoordination of ataxic and non-ataxic animals was
evaluated with rota-rod testing. Preliminary experiments showed
that mutant animals had a moderate level of motor discoordina-
tion at 4 weeks of age, and that the disease progressed over time.
As shown in Fig. 8A, a low dose of NK-4 (20 mg/kg) elicited a
moderate, but significant, effect in attenuating deterioration of
motor function that lasted for 2 weeks after 3 weeks of
administration. A high dose of NK-4 (100 mg/kg) gave a strong
effect that lasted for the whole test period. However, the rotation
time for animals in the treated group was not comparable to the
wild type controls, which were able to stay on a rotating rod for the
maximum testing period (180 s). The effect of NK-4 on motor
discoordination of hmPCDs was similarly observed in an inclined
plane task [39] (data not shown).
Figure 7. Overview of phenotype and behavioral disorders in the Purkinje cell-degenerated ataxic mutant hamster (hmPCD). (A)
Representative appearance of a male hmPCD and a wild type control at 18 months of age. (B) Rota-rod testing of hmPCDs and age-matched wild type
controls. The time spent on the rotating rod (6 rpm) is shown. (C) H&E-stained sections of the cerebellum from a hmPCD and a wild type control at 18
months of age. Purkinje cells are indicated with arrows. (D) Purkinje cell counts in cerebellar mid-sagittal sections from hmPCDs and wild type
controls at 18 months of age. Bars: 2 mm and 50 mm for low and high power fields, respectively. Graphs show the mean 6 SEM of 6 hamsters (3
males and 3 females). **P,0.01 vs. wild type control.
doi:10.1371/journal.pone.0017137.g007
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NK-4 treated animals was evaluated by counting the falling
frequency. The hmPCDs began to fall frequently in their cage from
around 7 weeks of age and the frequency of falling increased with
age. Animals treated with low and high dose NK-4 showed a
significant reduction in falling frequency compared to saline-
treated controls (Fig. 8B). These observations show that NK-4 is
effective for treating motor discoordination of cerebellar ataxia in
the hmPCD model.
Effect of NK-4 on cerebellar atrophy in hmPCD
We next examined the cerebellar sizes in the animals (Fig. 9A).
The mutants had severe cerebellar atrophy and volumetric
reduction (about 60% of age-matched wild type animals) at 10
weeks of age. In contrast, the volume of the cerebrum did not
differ significantly between mutants and wild type controls (data
not shown). Animals treated with low or high doses of NK-4 had a
significantly larger cerebellum volume compared with saline-
treated controls. Thus, NK-4 was effective in ameliorating motor
function and retaining cerebellar volume, which suggests that
maintenance of Purkinje cells function might be the key step for
achieving recovery of motor function.
H&E staining of the cerebellar cortex sections revealed a large
reduction in the number of cerebellar Purkinje cells in the brain of
hmPCDs at 10 weeks of age (Fig. 9B), which was further confirmed
by immunostaining of Purkinje cells with anti-calbindin antibody
(Fig. 9C). The number of calbindin-positive cells was well
correlated with the number of Purkinje cells (Fig. 9B) and
treatment with NK-4 (both low and high doses) significantly
attenuated the loss of calbindin-positive cells compared with
saline-treated controls. The dendrites of surviving calbindin-
positive cells in slices from saline-treated hmPCDs had degenerated
and weak features that made them difficult to find. In contrast,
calbindin-positive cells in slices from high dose NK-4-treated
hmPCDs had significantly longer and arborized dendrites (Fig. 9C).
In the brain of hmPCDs, the cerebellar granule cell density was
moderately (,80%) reduced compared to wild type controls, and
the granule cells in the cerebellum from control hmPCDs showed
atrophic feature (Fig. 9D). Effects of NK-4 against neuronal
degeneration were also found in this context. NK-4 dose-
dependently prevented the reduction of granule cells and
attenuated the granule cell atrophy. Typical examples of H&E-
stained sections of cerebellar white matter are shown in Fig. 9E.
Saline-treated ataxic mutants displayed moderate levels of
demyelination in cerebellar white matter (5/5 animals), while
fewer animals showed demyelination after treatment with low and
high doses of NK-4 (NK-4l; 4/5 animals, NK-4 h; 1/5 animals).
Discussion
Chronic neurodegenerative diseases are characterized by a
selective loss of specific neuronal populations over a period of
years. Although the underlying causes of most neurodegenerative
diseases are unclear, the loss of neurons and neuronal contacts is a
critical feature of the disease pathology. Development of a
compound that regulates neuronal cell death is a plausible
Figure 8. Effects of NK-4 on motor coordination in hmPCDs. (A) Effect of NK-4 on motor performance in the rota-rod test. Animals were tested
weekly for the ability to remain on the rotating rod, and the time spent on the rod is shown. (B) Effect of NK-4 on frequency of falling in hmPCDs.
Spontaneous falling of each animal was counted for 60 s and is presented as the falling frequency. Values are the mean 6 SEM of 5 animals per
group (2 males and 3 females). *P,0.05, **P,0.01 vs. vehicle-treated hmPCD.
doi:10.1371/journal.pone.0017137.g008
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generative disease. In this study, we showed that NK-4, a
photosensitizing cyanine dye, had neurotrophic effects, and found
that promotion of proliferation and neurite-outgrowth of PC12
cells by NK-4 was dependent on activation of PI3K-Akt and
occurred independently of Trk. Subsequently, we investigated the
effects of NK-4 in an animal model of cerebellar ataxia
attributable to Purkinje cell degeneration, and found that NK-4
effectively attenuated motor discoordination and prevented
degeneration of cerebellar Purkinje and granule cells.
More than 20 cyanine dyes have been shown to exhibit
neurotrophic effects, but NK-4 is one of the most potent agents for
promotion of growth and differentiation of PC12 cells. Radical
scavenging by NK-4 was also more effective than that of other
dyes, and this led us to examine NK-4 for treatment of
neurodegerative disease. In the present study, NK-4 clearly
promoted PC12 cell growth and neurite-outgrowth primed by
NGF. Consistent with these observations, ascorbate, a major
H2O2 scavenger, also promotes NGF- or cAMP-primed neurite-
outgrowth in PC12 cells [40,41]. A superoxide scavenger,
mitochondrial manganese superoxide dismutase (SOD), has also
been reported to induce neurite-outgrowth in PC12 cells, with
long term NGF-induced activation of extracellular signal-related
kinase (ERK1/2), which regulates neurite-outgrowth in PC12
cells, required for SOD activation [42]. NGF exerts a neuritogenic
effect by changing mitochondrial metabolism by reduction of ROS
produced by mitochondria and stabilization of the electrochemical
gradient. These observations suggest that NK-4 promotes neurite-
outgrowth in PC12 cells by reduction of ROS via induction and
maintenance of long term activation of ERK1/2.
Direct scavenging of free radicals may be one mechanism
through which NK-4 exerts neuronal protection against oxidative
damage. NK-4 protected PC12 cells from oxidative toxicities
induced by H2O2 and 6-OHDA in a significant and dose-
dependent manner (Fig. 2AB). However, NK-4 did not scavenge
H2O2, which suggests that NK-4 can detoxify radical species
generated from H2O2. ROS play pivotal roles in the pathogenesis
of neurodegenerative diseases, since increased formation of
superoxide radicals leads to increased of production of H2O2
due to (SOD) activity. In living cells, H2O2 is a major underlying
cause of oxidative damages [43], and is readily converted to highly
reactive hydroxyl radicals via a Fenton reaction in the presence of
iron ions [44,45]. These are the most oxidizing radicals known in
biological systems and may be involved in neurodegeneration.
NK-4 is a highly effective free radical scavenger for hydroxyl and
peroxy radicals and a moderate scavenger for superoxide [18];
therefore, NK-4 may detoxify these radical species before they
cause cellular damage.
We investigated whether TrkA and its downstream signal
transduction pathways were involved in NK-4-induced prolifera-
tion and neurite-outgrowth in PC12 cells. TrkA is the cell surface
receptor through which NGF mediates neuronal survival and
differentiation in PC12 cells [19]. K252a, an inhibitor of tyrosine
autophosphorylation of Trks, inhibited proliferation of PC12 cells
induced by NGF, but did not inhibit that induced by NK-4
(Fig. 3A). This result suggests that neurotrophic activity by NK-4 is
not mediated by TrkA or other K252a-sensitive molecules in
PC12 cells. Consistent with this observation, K252a also dose-
dependently inhibited NGF-induced neurite extension in PC12
cells, but did not effectively inhibit that induced by NK-4 primed
with NGF (Fig. 3B). This indicates that neuronal cell growth
induced by NK-4 occurred independently of Trk activation, but
that neurite-outgrowth in PC12 cells required activation of K252a-
sensitive Trk receptors. In contrast, LY294002, a specific inhibitor
of PI3K, affected cell growth induced by both NK-4 and NGF
(Fig. 4A) and inhibited neurite-outgrowth induced by NGF and
NK-4 primed with NGF (Fig. 4B) in PC12 cells. These results
suggest that PI3K is an essential regulator of NK-4-mediated
effects. NK-4 also induced phosphorylation of Akt, a downstream
regulator of PI3K, in PC12 cells (Fig. 5), which indicates that the
PI3K-Akt signaling pathway is affected by NK-4.
In agreement with the activation of survival signaling pathways,
we also showed an effect of NK-4 on SAPK/JNK activation
induced by H2O2. This pathway is relevant to neuronal death
because neurons undergo apoptosis through the SAPK/JNK
pathway. SAPK/JNK is also activated by neurotrophic factors
such as NGF, and this process is a key for neurotrophic factor-
mediated neuronal apoptosis. NGF induces SAPK/JNK activa-
tion within 1 day of treatment [46], whereas NK-4 (,6.3 mM) did
not induce SAPK/JNK activation for up to 3 days (data not
shown). This result is consistent with our previous observation that
NK-4 mediated signaling is independent of neurotrophin receptors
because SAPK/JNK is a downstream effector of Trks [46]. In the
present study, NK-4 inhibited H2O2-induced activation of SAPK/
JNK in PC12 cells (Fig. 6), and the viability of PC12 cells subjected
to H2O2 toxicity with or without treatment with NK-4 was
negatively correlated with SAPK/JNK phosphorylation. Thus,
NK-4 might activate the survival signaling cascade and inhibit the
death signaling cascade independently through a Trk-mediated
pathway, and this may provide protection against the neurotoxic
environment. We did not determine whether the low affinity p75
neurotrophin receptor for NGF might also be a target of NK-4,
but this appears unlikely because selective activation of p75 NTR
by NGF stimulates JNK activity and apoptotic cell death [47], in
contrast to the inability of NK-4 to activate JNK and apoptosis.
The effect of NK-4 against neurodegeneration was confirmed in
an animal model of ataxia. We recently showed that NK-4
attenuated brain injury and improved motor function in a rat
middle cerebral artery occlusion model [18]. This study indicated
the efficacy of NK-4 on the central nervous system (CNS);
however, the administration route remained in question because
disruption of the blood-brain barrier in this model [48] might
change the permeability of NK-4. Therefore, we used a genetic
animal model of ataxia (hmPCD) to evaluate the effect of NK4 on
neurodegenerative disease. This animal model reflects the
pathogenesis of human spinocerebellar ataxia [24], and exhibits
Figure 9. Effects of NK-4 on cerebellar atrophy and histopathology in hmPCDs. (A) Effect of NK-4 on cerebellar size in hmPCDs. Brains from
10-week-old animals were photographed from a constant distance and the cerebellar volume was calculated. (B) Effect of NK-4 on the Purkinje cell
frequency in hmPCDs. Purkinje cells in the Purkinje cell layer were counted in the mid-sagittal section of the cerebellum from hmPCDs. (C)
Immunohistochemistry using an anti-calbindin antibody on cerebellum sections for wild type (a), saline-treated hmPCD (b), and high dose NK-4
(100 mg/kg)-treated hmPCD (c). Bar: 30 mm. (D) Granule cell density in the cerebellum from hmPCDs and wild type controls. H&E stained sections of
cerebellum cortex from hmPCDs and wild type controls were photographed and counted for granule cells in an area of 20000 mm
2 (a). Representative
images for wild type (b), saline-treated hmPCD (c), and high dose NK-4-treated hmPCD (d). Bar: 10 mm. Graphs show the mean 6 SEM of 6 hamsters at
10 weeks of age (3 males and 3 females). *P,0.05, **P,0.01 vs. hmPCD control. (E) Attenuation of cerebellar demyelination in the white matter.
Representative microphotographs of cerebellar white matter for wild type (a), saline-treated hmPCD (b), and high dose NK-4-treated hmPCD (c).
Bar: 50 mm.
doi:10.1371/journal.pone.0017137.g009
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Purkinje cells and a mild reduction of granule cells, along with
decreased thickness of the molecular layer and internal granule
layer. In contrast, the cerebral hemisphere has no altered features
and no neurodegeneration [23]. The gene responsible for this
cerebellar atrophy is Nna1, which encodes a putative nuclear
protein containing a zinc carboxypeptidase domain initially
identified by its induction in spinal motor neurons during axonal
regeneration [25]. Blood-brain barrier permeability in this animal
model is unlikely to be affected by Nna1. In the hmPCD model, 20
or 100 mg/kg NK-4 was effective in attenuating motor discoordi-
nation and Purkinje cell loss with no toxic effects. This suggests
that NK-4 can attenuate neurodegeneration in the CNS via a
peripheral route of administration. The dose of NK-4 used in this
study was equivalent to that used in the rat middle cerebral artery
occlusion model. From these observations, NK-4 would cross the
blood-brain barrier and acted directly on degenerating neurons
and protected against cell damage. The concentration of NK-4 in
the cerebellum of hmPCDs remains in question. In our preliminary
study, NK-4 penetrated into the cerebellum, and was detected at
nM levels in the cerebellum from 15 min after intraperitoneal
administration in hamster (100 mg/kg) using high-performance
liquid chromatography detection system. The concentration found
in cerebellum was comparative to that found in plasma. These
results were consistent with the in vitro observations that nM levels
of NK-4 was sufficient to exert its neurotrophic effects.
Purkinje cells are susceptible to ischemic damage because of
their reduced capacity to isolate glutamate and reduced ability to
generate energy during anoxia [49]. Granule cells are also
vulnerable to a variety of toxins that decrease glutathione levels
and this make the cells more vulnerable to DNA and other cellular
damage from ROS [50,51]. Direct scavenging of free radicals by
NK-4 may protect these cells. In addition, NK-4 seems to activate
survival signaling pathways in degenerating cerebellar neurons.
This is supported by the protection of Purkinje and granule
neurons from cell death by activation of a PI3K-Akt dependent
mechanism [52,53]. Calbindin-positive Purkinje cells in NK-4-
treated animals possessed longer and well-branched neurites, in
contrast to the feeble dendrites in saline-treated hmPCDs, which
suggests functional differences (Fig. 9C) between neurons in these
animals. This might provide a better explanation of the improved
motor coordination in the NK-4-treated animals, rather than
dependence on the Purkinje cell number. The number of granule
neurons in treated animals was also higher than that in the saline-
treated controls (Fig. 9D). This result is consistent with the
observation that Purkinje cells provide critical trophic support to
developing cerebellar granule neurons [54]. Granule cells are the
most abundant and provide input to the Purkinje cells, whose
axons are the sole output from the cerebellar cortex and provide
input to multiple target cells. These observations suggest that the
attenuation of cerebellar atrophy by NK-4 may be a result of
restoration of these two main cell types.
In summary, we conclude that NK-4 exerts neurotrophic
activity both in vitro and in vivo, and that this activity may be
mediated partially through direct free radical scavenging,
especially of hydroxyl and peroxy radicals. Analysis of signaling
events revealed that the PI3K-Akt survival signaling cascade was
triggered by NK-4 without Trk activation. Results in an ataxic
animal model demonstrated the preclinical efficacy of NK-4 and
suggested its potential utility as a treatment for neurodegenerative
disease. Assessment of NK-4 in human neurodegenerative therapy
will require further studies. A safety evaluation and the
pharmacokinetics of NK-4 are currently being investigated.
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